Comparison Between Processes of HTA, Pharmaceutical Pricing and Reimbursement, and Their Transparency in Germany and Poland
Comparison Between Processes of HTA, Pharmaceutical Pricing and Reimbursement, and Their Transparency in Germany and Poland
Author(s): Hanna Wüller, Christoph Sowada, Tomasz BochenekSubject(s): Politics, Economy, Health and medicine and law
Published by: Wydawnictwo Uniwersytetu Jagiellońskiego
Keywords: Germany; health technology assessment; pharmaceutical policy; Poland; pricing and reimbursement of pharmaceuticals; transparency;
Summary/Abstract: This paper focuses on HTA, pricing and reimbursement of pharmaceuticals in Germany and Poland. The authors analyzed processes of decision making related to pharmaceutical reimbursement, as well as their transparency. Both Germany and Poland have developed complex processes of pharmaceutical pricing and reimbursement, as well as incorporated HTA into decision making procedures. In Germany the stakeholders involvement and transparency of processes seem to be to higher than in Poland.
Journal: Zdrowie Publiczne i Zarządzanie
- Issue Year: 13/2015
- Issue No: 1
- Page Range: 102 - 108
- Page Count: 7
- Language: English
